A clinical trial to study effect of Pippali in Bronchial Asthma using Pippali powder with honey

Study of efficacy of Pippali powder with honey in Bronchial asthma(tamak shwasa)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/10/010124

Enrollment

Registered

2017-10-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Asthma

Interventions

Intervention1: Pippali churna: Pippali churna 2gm thrice a day with honey Oraly For 28 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1-presence of symtoms of airflow obstruction 2-airflow obstruction is at least partially reversible. 3-oxygen saturation > 90 4-cases included from intermittent mildly persistent to moderate persistent asthma. 5-age 18 -70 years.

Exclusion criteria

Exclusion criteria: oxygen saturation 2-chronicity more than 10 years. 3-asadhya lakshanas of tamaka shwasa 4-the patient with H/o tuberculosis copd emphysema etc. 5-H/o endocrine disorders like diabetes mellitus 6-if the patient exhibits short seasonal changes of less than 4 weeks duration

Design outcomes

Primary

Measure	Time frame
To decrease cough,dyspnoea of asthma patientTimepoint: 28days	—

Secondary

Measure	Time frame
Along with dyspnoea, cough also reduce the frequency of status asthamaticusTimepoint: 28days	—

Countries

India

Contacts

Public Contactshailendra kumar

tilak ayurved mahavidyalay pune

principaltamv@gmail.com9960071113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026